March 14, 2022
Belong.life, creator of the world’s largest social and professional network for cancer patients, recently launched a dedicated platform for people with chronic myeloid leukaemia (CML). Health Tech World speaks to chief medical director Dr. Daniel Vorobiof to find out more.
HTW: How did the community for CML patients come about?
DV: Our dedicated CML community came about after numerous requests from patients and caregivers to create a space specific to this disease.
Chronic myeloid leukaemia, also known as chronic myelogenous leukaemia, is a slow-progressing cancer that originates in the bone marrow, typically affecting older adults, and comprises about 15% of new leukemia diagnoses in the U.S.
How will the tool enhance engagement and real-life treatment journeys for users?
CML and the treatment experiences of patients with this disease change over time. Our CML Tracker is an innovative tool that allows patients to keep track of their symptoms over the course of their disease and treatment.
Our users can keep a record of their experiences living with CML and treatment journeys, providing them with useful information they can share with their doctor for more productive conversations. This tool is to enhance the ongoing engagement between patients and their medical teams.
Eventually, we hope to gather the anonymous insights from this patient user base to contribute towards global research focused on this disease, with the ultimate goal of improving CML patients’ quality of life.